DELISHAJ, DURIM
 Distribuzione geografica
Continente #
NA - Nord America 1.002
EU - Europa 373
AS - Asia 125
AF - Africa 45
OC - Oceania 1
Totale 1.546
Nazione #
US - Stati Uniti d'America 985
IT - Italia 130
SE - Svezia 108
CN - Cina 62
BG - Bulgaria 36
SG - Singapore 35
DE - Germania 31
CI - Costa d'Avorio 21
AT - Austria 19
GB - Regno Unito 17
VN - Vietnam 17
CA - Canada 15
FI - Finlandia 14
SN - Senegal 12
FR - Francia 10
NG - Nigeria 9
HK - Hong Kong 6
IN - India 3
MG - Madagascar 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
MX - Messico 2
PK - Pakistan 2
AU - Australia 1
BE - Belgio 1
CH - Svizzera 1
UA - Ucraina 1
Totale 1.546
Città #
Woodbridge 150
Fairfield 124
Chandler 104
Ann Arbor 77
Houston 65
Ashburn 56
Seattle 55
Cambridge 53
Wilmington 48
Sofia 36
Serra 32
Beijing 29
New York 24
Abidjan 21
Boardman 19
Vienna 19
Florence 17
Lawrence 15
Ottawa 15
Princeton 15
Medford 13
Pisa 13
Dakar 12
Des Moines 11
Dong Ket 11
Singapore 10
Lagos 9
Frankfurt am Main 8
London 8
Bremen 7
Dearborn 7
Massa E Cozzile 7
Detroit 6
Hong Kong 6
Lancaster 6
Nanjing 6
Redwood City 6
Helsinki 5
Los Angeles 4
Ogden 4
Zhengzhou 4
Antananarivo 3
Boulder 3
Falls Church 3
Indiana 3
Milan 3
Munich 3
San Diego 3
San Francisco 3
Shanghai 3
Brno 2
Genoa 2
Hicksville 2
Jiaxing 2
Kent 2
Kunming 2
Nürnberg 2
Phoenix 2
Shenyang 2
Siena 2
Taiyuan 2
Troina 2
Vicopisano 2
Bari 1
Brussels 1
Bryan 1
Böblingen 1
Capannori 1
Changchun 1
Changsha 1
Chehalis 1
Chengdu 1
Edinburgh 1
Erlangen 1
Hebei 1
Islamabad 1
Jinan 1
Kilburn 1
Limeil-brévannes 1
Lucca 1
Marseille 1
Nanchang 1
New Delhi 1
Norwalk 1
Redmond 1
Royal Oak 1
Sydney 1
Tambov 1
Taramani 1
Tianjin 1
Wenzhou 1
Totale 1.218
Nome #
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy 185
The effectiveness of bevacizumab in radionecrosis after radiosurgery of a single brain metastasis 161
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature 148
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 136
Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience 122
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 121
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis 113
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 111
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature 106
The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients 86
Role of perfusion CT in the evaluation of metastatic nodal tumor response after radiochemotherapy in head and neck cancer: preliminary findings 86
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology 66
Concomitant external-beam irradiation and chemotherapy followed by high-dose rate brachytherapy boost in the treatment of squamous cell carcinoma of the vagina: A single-center retrospective study 65
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 64
Non-melanoma skin cancer treated with high-doserate brachytherapy and Valencia applicator in elderly patients: a retrospective case series 20
Integrating stereotactic radiotherapy and systemic therapies 5
Totale 1.595
Categoria #
all - tutte 4.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020288 0 0 28 36 30 37 38 35 33 26 17 8
2020/2021118 6 13 5 1 10 11 11 9 16 15 2 19
2021/2022161 3 4 0 12 35 20 3 9 11 2 12 50
2022/2023352 38 61 33 18 37 35 2 24 68 0 30 6
2023/2024139 10 9 23 3 18 30 5 5 7 4 7 18
2024/202525 1 23 1 0 0 0 0 0 0 0 0 0
Totale 1.595